|
Treatment
|
---|
Time (Weeks)
|
Control
|
Bti
|
Spinosad
|
Temephos
|
---|
Pre-treatment
| | | | |
-5
|
0.0 ± 0.0a
|
4.8 ± 2.3a
|
2.5 ± 2.2a
|
2.3 ± 2.3a
|
-4
|
0.0 ± 0.0b
|
0.0 ± 0.0b
|
2.3 ± 1.9ab
|
5.0 ± 4.4a
|
-3
|
9.5 ± 8.2a
|
18.0 ± 12.8a
|
12.3 ± 10.0a
|
15.8 ± 15.1a
|
-2
|
1.3 ± 0.8a
|
11.3 ± 6.0a
|
4.0 ± 1.7a
|
1.0 ± 1.0a
|
-1
|
8.0 ± 5.7a
|
19.8 ± 5.1a
|
25.3 ± 14.9a
|
31.8 ± 22.2a
|
Post-treatment
| | | | |
1
|
1.3 ± 0.8a
|
5.5 ± 5.5a
|
0.0 ± 0.0a
|
0.0 ± 0.0a
|
2
|
0.8 ± 0.8b
|
9.8 ± 5.5a
|
0.0 ± 0.0b
|
0.0 ± 0.0b
|
3
|
2.5 ± 2.5b
|
13.0 ± 5.6a
|
0.0 ± 0.0b
|
0.0 ± 0.0b
|
4
|
3.3 ± 3.3ab
|
9.3 ± 6.6a
|
0.0 ± 0.0b
|
0.0 ± 0.0b
|
5
|
4.8 ± 4.1a
|
1.5 ± 0.6ab
|
0.0 ± 0.0b
|
0.0 ± 0.0b
|
6
|
0.0 ± 0.0b
|
4.0 ± 1.8a
|
4.5 ± 4.5a
|
0.0 ± 0.0b
|
7
|
1.5 ± 1.5a
|
0.8 ± 0.8a
|
1.5 ± 1.5a
|
0.0 ± 0.0a
|
8
|
0.0 ± 0.0b
|
4.0 ± 1.4a
|
0.0 ± 0.0b
|
0.0 ± 0.0b
|
9
|
1.5 ± 1.2a
|
1.5 ± 1.0a
|
0.0 ± 0.0a
|
0.0 ± 0.0a
|
10
|
7.5 ± 5.7a
|
7.5 ± 5.2a
|
0.0 ± 0.0b
|
2.3 ± 2.3a
|
11
|
2.5 ± 1.0a
|
4.0 ± 3.4a
|
0.0 ± 0.0b
|
11.5 ± 9.3a
|
12
|
5.5 ± 4.6a
|
0.3 ± 0.3b
|
0.3 ± 0.3b
|
0.0 ± 0.0b
|
13
|
11.8 ± 7.9a
|
27.3 ± 7.5a
|
0.0 ± 0.0b
|
21.5 ± 20.2a
|
14
|
7.5 ± 5.7a
|
6.8 ± 4.2a
|
0.0 ± 0.0b
|
0.8 ± 0.8b
|
15
|
11.8 ± 3.9a
|
10.3 ± 2.5a
|
0.0 ± 0.0b
|
8.0 ± 3.4a
|
20
|
20.5 ± 3.5a
|
26.5 ± 19.3a
|
2.0 ± 2.0b
|
16.3 ± 4.5a
|
- Values followed by identical letters did not differ significantly for comparisons within rows (mixed model analysis on ln (x + 1) transformed values with Toeplitz correlation structure, P > 0.005 following Bonferroni correction).